183
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Natural Human Interferon-Beta in Metastatic Malignant Melanoma: A phase II study

, &
Pages 815-817 | Published online: 07 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (8)

Meghana Ramani, Miranda C. Mudge, R. Tyler Morris, Yuntao Zhang, Stanislaw A. Warcholek, Miranda N. Hurst, Jim E. Riviere & Robert K. DeLong. (2017) Zinc Oxide Nanoparticle–Poly I:C RNA Complexes: Implication as Therapeutics against Experimental Melanoma. Molecular Pharmaceutics 14:3, pages 614-625.
Crossref
Ernest C. BordenBarbara JacobsEmese HollovaryLisa RybickiPaul ElsonThomas OlenckiPierre Triozzi. (2011) Gene Regulatory and Clinical Effects of Interferon β in Patients with Metastatic Melanoma: A Phase II Trial. Journal of Interferon & Cytokine Research 31:5, pages 433-440.
Crossref
Ian S. Dunn, Timothy J. Haggerty, Michihiro Kono, Paul J. Durda, David Butera, David B. Macdonald, Elizabeth M. Benson, Lenora B. Rose & James T. Kurnick. (2007) Enhancement of Human Melanoma Antigen Expression by IFN-β. The Journal of Immunology 179:4, pages 2134-2142.
Crossref
Ernest C. Borden. (2005) Review: Milstein Award Lecture: Interferons and Cancer: Where from Here? . Journal of Interferon & Cytokine Research 25:9, pages 511-527.
Crossref
Ernest C. Borden. 2002. Melanoma. Melanoma 235 258 .
Constantin E. Orfanos & Claus GarbeConstantin E. Orfanos & Claus Garbe. 1995. Therapie der Hautkrankheiten. Therapie der Hautkrankheiten 1021 1041 .
A. Görlach, P. Herter, H. Hentschel, P. J. Frosch & H. Acker. (2006) Effects of nIFN β and rifn γ on growth and morphology of two human melanoma cell lines: Comparison between two‐and three‐dimensional culture. International Journal of Cancer 56:2, pages 249-254.
Crossref
John M. Kirkwood & Marc S. Ernstoff. (1990) Role of Interferons in the Thearpy of Melanoma. Journal of Investigative Dermatology 95:6, pages S180-S184.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.